Rich countries donating half their Covid vaccine supply would be a “win-win”

Publicly released:
Australia; New Zealand
PHOTO: Pixabay
PHOTO: Pixabay

New modelling has found that wealthy countries donating 46 per cent of their Covid vaccine supply to low- and middle-income countries could help lower the latter’s Covid death rate and protect against new strains globally. According to their five-year model, there’s only a short-term benefit for wealthy countries when they hold on to their supplies; after the first year, they become more vulnerable to infections. However, sharing their supply was found to be mutually beneficial by slowing down the development of new variants. The authors say it’d be a practical way to achieve vaccine equity if wealthy countries start making more generous donations to their low- and middle-income neighbours.

Media release

From: Springer Nature

Increasing the portion of COVID-19 vaccines donated from high-income countries to low-and-middle-income countries to 46% of the former’s total supply could lead to substantial decreases in mortality in low-and-middle-income countries, and protect against new strains and pandemic waves worldwide, according to a modelling study in Nature Human Behaviour. These findings emphasize that global vaccine equity is essential for suppressing pandemic waves caused by new variants, and can be practically achieved by immediate and more-generous vaccine donations to low-and-middle-income countries.

The global distribution of COVID-19 vaccines is imbalanced, with high-income countries (HICs) receiving a far greater share than low-and-middle-income countries (LMICs). This inequity has resulted in continued, high rates of infections and deaths in LMICs, whilst the recent emergence of new variants of SARS-CoV-2 threatens advances made by HICs in disease control and economic recovery.

Using a mathematical model, Qingpeng Zhang, Daniel Zeng and colleagues project the consequences of vaccine inequity over five years, against the backdrop of evolving strains of SARS-CoV-2 and global mobility. Although inequitable vaccination leads to a faster decline in mortality in HICs in the first year, it extends the duration of the pandemic globally. HICs become vulnerable to rises in infections after the first year, as a higher probability of emerging strains in LMICs increases the risk globally. Conversely, equitable vaccine allocation strategies can substantially curb the spread of new strains and provide greater benefits to both HICs and LMICs. Increasing vaccine donations to 46% of total HIC vaccine supply would lead to substantial decreases in mortality in LMICs and could protect all countries against new strains and pandemic waves.

The authors conclude that these findings emphasize not only the value of examining the long-term influence of vaccines on the emergence of new strains of SARS-CoV-2, but also the need to improve global vaccine allocation strategies. In an associated News & Views, Dan Yamin states that “subsidizing COVID-19 vaccination in LMICs is a practically sound, moral obligation of HICs — and it also happens to be in their own self-interest.”

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Springer Nature, Web page URL will go live when embargo lifts.
Journal/
conference:
Nature Human Behaviour
Research:Paper
Organisation/s: City University of Hong Kong, Hong Kong, China; Shanghai Jiao Tong University, China; Chinese Academy of Sciences, China;
Funder: This work was supported in part by the Research Grants Council of the Hong Kong Special Administrative Region, China (grant nos 11218221, C7154-20GF, C7151-20GF and C1143-20GF to Q.Z.), in part by the National Natural Science Foundation of China (grant nos 71621002 and 72025404 to Z.C. and D.D.Z.), in part by the Strategic Priority Research Program of the Chinese Academy of Sciences (grant no. XDA27030100 to Z.C. and D.D.Z.) and in part by the Health and Medical Research Fund (grant no. COVID190215 to H.-Y.Y. and Q.Z.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Media Contact/s
Contact details are only visible to registered journalists.